麻疹和风疹消除可行性评估
本报告应2017年第七十届世界卫生大会总干事要求,从流行病学角度评估麻疹和风疹消除的可行性及潜在资源需求。报告强调消除路径应服务于加强初级卫生保健、促进全民健康覆盖,并作为《2030年免疫议程》新愿景和战略的探路者。报告涵盖全球麻疹和风疹现状、既往可行性评估、区域消除进展与挑战、建模和经济分析结果、消除目标设定及前提条件框架,并以SAGE认可的建议作结。
要点
- 麻疹和风疹消除路径应加强初级卫生保健并促进全民健康覆盖。
- 报告评估了区域消除进展与挑战及额外考量(建模和经济分析)。
- 提出了确定消除目标日期前提条件的框架及SAGE认可的建议。
核心结论
- 麻疹和风疹消除应作为全球卫生优先事项,其路径应服务于加强初级卫生保健、促进全民健康覆盖,并作为《2030年免疫议程》的探路者。
研究设计与样本
- 本报告为应2017年5月31日第七十届世界卫生大会总干事要求而编写的可行性评估报告,涵盖流行病学方面及潜在资源需求。
主要发现
- 报告强调了麻疹和风疹作为全球卫生优先事项的重要性。
- 报告回顾了当前全球麻疹和风疹形势。
- 报告总结了既往麻疹和风疹消除可行性评估。
- 报告评估了实现区域麻疹和风疹消除的进展与挑战。
- 报告评估了麻疹和风疹消除的额外考量,包括建模和经济分析结果。
关键数值与推荐
- 报告评估了建立麻疹和风疹消除目标的含义及设定消除目标日期的过程。
- 报告提出了确定设定麻疹和风疹消除目标日期前提条件的框架,并说明了如何理解和运用这些前提条件。
- 报告以SAGE认可的建议作结。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This report addresses the epidemiological aspects and feasibility of measles and rubella eradication and the potential resource requirements in response to the request of the Director-General at the Seventieth World Health Assembly held on May 31, 2017. A guiding principle is that the path toward measles and rubella eradication should serve to strengthen primary health care, promote universal health coverage, and be a pathfinder for new vision and strategy for immunization over the next decade as laid out in the Immunization Agenda 2030. Specifically, this report: 1) highlights the importance of measles and rubella as global health priorities; 2) reviews the current global measles and rubella situation; 3) summarizes prior assessments of the feasibility of measles and rubella eradication; 4) assesses the progress and challenges in achieving regional measles and rubella elimination; 5) assesses additional considerations for measles and rubella eradication, including the results of modelling and economic analyses; 6) assesses the implications of establishing a measles and rubella eradication goal and the process for setting an eradication target date; 7) proposes a framework for determining preconditions for setting a target date for measles and rubella eradication and how these preconditions should be understood and used; and 8) concludes with recommendations endorsed by SAGE.
引用
- Moss WJ, Shendale S, Lindstrand A, et al. Feasibility assessment of measles and rubella eradication. Vaccine. 2021. PMID: 34045102. doi:10.1016/j.vaccine.2021.04.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。